| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387829A1 Novel pyridinone and related heterocyclic derivatives |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387698A2 Method of preventing cell death using antibodies to neural thread proteins |
| 02/11/2004 | EP1387685A1 Analgesic composition and method |
| 02/11/2004 | EP1387682A1 Treatment of adhd |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387678A1 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation |
| 02/11/2004 | EP1387673A1 Abuse-resistant controlled-release opioid dosage form |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1289544B1 Method for treating a movement disorder |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1123087A4 Oral pulsed dose drug delivery system |
| 02/11/2004 | EP1032561B1 Substituted oximes as neurokinin antagonists |
| 02/11/2004 | EP1011712B1 Combination of cytokines having neurotrophic activity |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | EP0835125B1 Cd4-derived peptides that inhibit immune responses |
| 02/11/2004 | EP0781127B1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 02/11/2004 | CN1474820A Benzodiazepine derivatives as GABA A receptor modulators |
| 02/11/2004 | CN1474813A Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474808A Method for producing chipal compounds |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474692A Treatment of premature ejaculation |
| 02/11/2004 | CN1474691A Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1473935A GST fusion expression of conotoxin MVII A gene and its use |
| 02/11/2004 | CN1473618A Chinese patent medicine for treating senile dementia and its prearing process |
| 02/11/2004 | CN1473616A Medicine for treating head wind syndrome |
| 02/11/2004 | CN1473605A Medicine for reieving methal stress and promoting intelligence growth and producing method |
| 02/11/2004 | CN1473564A New use of manumycin |
| 02/11/2004 | CN1473531A Filling material of natural flower fragrance health pillow |
| 02/11/2004 | CN1137988C Wine for giving-up smoking |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 02/11/2004 | CN1137705C Medicine for treating mental disease (psychosis) and its preparing method |
| 02/11/2004 | CN1137704C Chinese medicinal preparation for treating mental disease (psychosis) |
| 02/11/2004 | CN1137698C Preparation containing peanut leaf extract and its preparing process |
| 02/11/2004 | CN1137686C Remedies for spinal canal stenosis |
| 02/11/2004 | CN1137626C Tea for refreshing and sobering up and its preparing process |
| 02/10/2004 | USRE38425 Semicarbazones having CNS activity and pharmaceutical preparations containing same |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689816 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
| 02/10/2004 | US6689813 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects |
| 02/10/2004 | US6689812 Can be administered with conventional drugs to treat psychiatric or central nervous disorders to improve their efficacy or reduce their side effects |
| 02/10/2004 | US6689808 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689795 Methods for treating dementia due to HIV disease |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689790 Substituted triazolopyridine compounds |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689783 Aryl oxime-piperazines useful as CCR5 antagonists |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6689557 Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
| 02/10/2004 | US6689384 Stable pergolide mesylate and process for making same |
| 02/10/2004 | US6689373 Implanting a drug delivery device; fentanyl or a fentanyl congener (e.g., sufentanil) |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/10/2004 | US6689350 Therapeutic polyesters and polyamides |
| 02/10/2004 | US6689339 Freckles |
| 02/10/2004 | CA2291975C Quaternary ammonium compounds |
| 02/10/2004 | CA2262652C Anti-stress drugs and functional foods having anti-stress effects |
| 02/10/2004 | CA2229597C Oral fast-dissolving compositions for dopamine agonists |
| 02/10/2004 | CA2223551C Benzimidazole compounds |
| 02/10/2004 | CA2214247C Modulators of amyloid aggregation |
| 02/10/2004 | CA2180301C Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 02/05/2004 | WO2004011632A2 Oligodendrocyte production from multipotent neural stem cells |
| 02/05/2004 | WO2004011470A1 Furoisoquinoline derivative and use thereof |
| 02/05/2004 | WO2004011468A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/05/2004 | WO2004011465A1 Kinase inhibitors |
| 02/05/2004 | WO2004011464A2 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011441A1 Pyridazinylpiperazine derivatives for treating pain |
| 02/05/2004 | WO2004011430A1 Sodium channel inhibitor |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011416A1 CRYSTALLINE β2 ADRENERGIC RECEPTOR AGONIST |
| 02/05/2004 | WO2004011413A1 Sertraline |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004011031A1 Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic |
| 02/05/2004 | WO2004011028A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | WO2004011002A1 Sustained-release tablet composition comprising a dopamine receptor agonist |
| 02/05/2004 | WO2004010999A1 Pramipexole once-daily dosage form |
| 02/05/2004 | WO2004010998A1 Sustained-release tablet comprising reboxetine |
| 02/05/2004 | WO2004010997A1 Sustained-release tablet composition of pramipexole |